WAM
JAZZ icon

Wolverine Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wolverine Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-45,000
Closed -$6.58M – 1522
2017
Q3 		$6.58M Hold
45,000
– – 0.07% 208
2017
Q2 		$7M Buy
+45,000
New +$6.88M 0.09% 189

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Wolverine Asset Management's JAZZ Position: Q2 2026 in Review

Wolverine Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 76% in Q2 2026, buying an estimated $221K and bringing the position to 2,330 shares worth $561K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Wolverine Asset Management first reported a position in JAZZ in Q1 2020 and has held it in 13 quarters since. The position peaked at $1.69M in Q2 2024. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Wolverine Asset Management held 2,330 shares of Jazz Pharmaceuticals worth $561K as of Q2 2026.
  • Wolverine Asset Management bought 1,008 Jazz Pharmaceuticals shares in Q2 2026, an estimated $221K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #922 holding.
  • Wolverine Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 13 quarters since.
  • Wolverine Asset Management's Jazz Pharmaceuticals position peaked at $1.69M in Q2 2024.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.